Search Results 361-370 of 17394 for Oncogene

  1. A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma - Mayo Clinic

    Unknown v-Raf murine sarcoma viral oncogene homolog B1 (BRAF) V600 mutation status as described in the protocol. Prior/Concomitant Therapy: 5. Prior immune ...

  2. A Study to Evaluate the Safety and Effectiveness of AB928-Based Treatment Combinations to Treat Patients with Metastatic Colorectal Cancer - Mayo Clinic

    - Mutation in the BRAF oncogene. Patients with unknown BRAF status will be required to undergo testing at a local laboratory and provide results at ...

  3. Hepatitis B-Associated Hepatocellular Carcinoma: Variation in Therapeutic Response Mediated by Viral Integration - Mayo Clinic Research

    Hepatitis B virus is an oncogenic virus that is the most common cause of hepatocellular carcinoma, with high prevalence rates of chronic infection in Africa and ...

  4. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic Researchers Find Two Oncogenes Join to Drive Lung Squamous Cell Carcinoma. Kevin Punsky. February 10, 2014. Infectious Diseases.

  5. Publications - Craig M. Horbinski, M.D. - Mayo Clinic

    Oncogenic long noncoding RNA LINC02283 enhances PDGF receptor A-mediated signaling and drives glioblastoma tumorigenesis. Neuro Oncol. 2023 Sep 5; 25 (9): ...

  6. Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations - Mayo Clinic

    ... oncogene homolog 1 (AKT1), MTOR, phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha (PIK3CA), tuberous sclerosis (TSC)1, TSC2 ...

  7. Faculty - Department of Cancer Biology - Mayo Clinic Research

    Cancer Biology. Sections. Overview · Faculty; Research Research. Focus Areas · Cancer Disparities · Cancer Stem Cells · Cancer Systems Biology · Oncogenic Gene ...

  8. Squamous Cell Carcinoma Of The Skin Clinical Trials - Mayo Clinic Research

    Cells with increased oncogene activity adopt a secretory phenotype. ... We hypothesize that the secretion of ECM proteins is an early event in malignant ...

  9. Publications - Julie E. Hallanger Johnson, M.D. - Mayo Clinic

    Impact of oncogene panel results on surgical management of cytologically indeterminate thyroid nodules. Head & Neck. 2018; 40(8):1812-1823. Epub 2018 Apr 06 ...

  10. Overview - Oncoimmune Signaling and Therapeutics - Mayo Clinic Research

    The laboratory is using new knowledge derived from our research to develop innovative therapeutic approaches to restore antitumor immunity across a range of ...